Michael R. Hayden - 12 Jun 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Director
Signature: Tryn Stimart, attorney-in-fact
Issuer symbol: ABCL
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Jul 2025, 15:13:15 UTC
Previous filing: 02 May 2025
Next filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hayden Michael R	Director	C/O ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA	Tryn Stimart, attorney-in-fact	01 Jul 2025	0001352908

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Award	$0	+238,864	+36%	$0.000000	899,843	12 Jun 2025	Common Shares	238,864	$3.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.